Clarify Health is the proud recipient of Frost & Sullivan’s 2021 New Product Innovation Award. Our real-world evidence (RWE) solutions for the life sciences industry were chosen for their ability to deliver on-demand precision insights, exceptional customer experience, and greater return on investment.

“Clarify’s RWE cloud platform is modernizing how life sciences organizations realize precision insights, said Pavel Zhebrouski, Best Practices Research Analyst, Frost & Sullivan. “Their customers work faster—testing hypotheses instantly and receiving insights with machine learning precision in seconds. The company is in a prime position to lead RWE IT solutions in life sciences. Frost & Sullivan is proud to present Clarify Health with this year’s Best Practices New Product Innovation Award in real-world evidence information technology (IT) solutions in the life sciences industry.”

With RWE software products, Clarify Growth and Clarify Portfolio, pharmaceutical, and biotechnology companies gain the unprecedented ability to explore and understand how medical care and social and behavioral determinants of health (SDoH) interconnect to influence each patient’s journey. The products are the fastest way to interrogate 300M+ unique patient journeys and 18 billion AI-powered predictions to precisely pinpoint the needs of any patient cohort and surface the most impactful real-world opportunities to improve outcomes. They have applications in clinical development, corporate development, and commercialization.

To read the full press release click here.